Market capitalization | $23.87b |
Enterprise Value | $23.69b |
P/E (TTM) P/E ratio | 48.89 |
EV/FCF (TTM) EV/FCF | 73.65 |
EV/Sales (TTM) EV/Sales | 8.23 |
P/S ratio (TTM) P/S ratio | 8.30 |
P/B ratio (TTM) P/B ratio | 8.68 |
Dividend yield | 0.24% |
Last dividend (FY23) | $0.78 |
As a Free StocksGuide user, you can view scores for all 6,892 stocks worldwide.
13 Analysts have issued a West Pharmaceutical Services, Inc. forecast:
13 Analysts have issued a West Pharmaceutical Services, Inc. forecast:
Sep '24 |
+/-
%
|
||
Revenue | 2,876 2,876 |
2%
2%
|
|
Gross Profit | 1,007 1,007 |
10%
10%
|
|
EBITDA | 747 747 |
11%
11%
|
EBIT (Operating Income) EBIT | 596 596 |
16%
16%
|
Net Profit | 500 500 |
11%
11%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
West Pharmaceutical Services, Inc. manufactures and markets pharmaceuticals, biologics, vaccines and consumer healthcare products. It operates through the following business segments: Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers proprietary packaging, containment and drug delivery products, along with analytical lab services, to biologic, generic and pharmaceutical drug customers. The Contract-Manufactured Products segment serves as a fully integrated business, focused on the design, manufacture and automated assembly of complex devices, primarily for pharmaceutical, diagnostic, and medical device customers. The company was founded by Herman O. West on July 27, 1923 and is headquartered in Exton, PA.
Head office | United States |
CEO | Eric Green |
Employees | 10,600 |
Founded | 1923 |
Website | www.westpharma.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.